144 related articles for article (PubMed ID: 37555392)
21. Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology.
Bofarid S; Hosman AE; Mager JJ; Snijder RJ; Post MC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801690
[TBL] [Abstract][Full Text] [Related]
22. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
[TBL] [Abstract][Full Text] [Related]
23. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
Kuehl HK; Caselitz M; Hasenkamp S; Wagner S; El-Harith el-HA; Manns MP; Stuhrmann M
Hum Mutat; 2005 Mar; 25(3):320. PubMed ID: 15712270
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.
Ruiz S; Chandakkar P; Zhao H; Papoin J; Chatterjee PK; Christen E; Metz CN; Blanc L; Campagne F; Marambaud P
Hum Mol Genet; 2017 Dec; 26(24):4786-4798. PubMed ID: 28973643
[TBL] [Abstract][Full Text] [Related]
25. Deficiency in hereditary hemorrhagic telangiectasia-associated Endoglin elicits hypoxia-driven heart failure in zebrafish.
Lelièvre E; Bureau C; Bordat Y; Frétaud M; Langevin C; Jopling C; Kissa K
Dis Model Mech; 2023 May; 16(5):. PubMed ID: 37264878
[TBL] [Abstract][Full Text] [Related]
26. Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics.
Gómez-Acebo I; Prado SR; De La Mora Á; Puente RZ; de la Roza Varela B; Dierssen-Sotos T; Llorca J
Orphanet J Rare Dis; 2020 Jun; 15(1):168. PubMed ID: 32600370
[TBL] [Abstract][Full Text] [Related]
27. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia.
Fontalba A; Fernandez-L A; García-Alegria E; Albiñana V; Garrido-Martin EM; Blanco FJ; Zarrabeitia R; Perez-Molino A; Bernabeu-Herrero ME; Ojeda ML; Fernandez-Luna JL; Bernabeu C; Botella LM
BMC Med Genet; 2008 Aug; 9():75. PubMed ID: 18673552
[TBL] [Abstract][Full Text] [Related]
28. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.
Lenato GM; Suppressa P; Giordano P; Guanti G; Guastamacchia E; Triggiani V; Amati L; Resta F; Covelli V; Jirillo E; Sabbà C
Curr Pharm Des; 2007; 13(36):3656-64. PubMed ID: 18220803
[TBL] [Abstract][Full Text] [Related]
29. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment.
Ardelean DS; Jerkic M; Yin M; Peter M; Ngan B; Kerbel RS; Foster FS; Letarte M
Angiogenesis; 2014 Jan; 17(1):129-46. PubMed ID: 24061911
[TBL] [Abstract][Full Text] [Related]
30. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.
Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S;
Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692
[TBL] [Abstract][Full Text] [Related]
31. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
[TBL] [Abstract][Full Text] [Related]
32. Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2.
Choi EJ; Kim YH; Choe SW; Tak YG; Garrido-Martin EM; Chang M; Lee YJ; Oh SP
PLoS One; 2013; 8(5):e63138. PubMed ID: 23675457
[TBL] [Abstract][Full Text] [Related]
33. [Rendu-Osler disease: clinical and molecular update].
Bailly S; Dupuis-Girod S; Plauchu H
Med Sci (Paris); 2010 Oct; 26(10):855-60. PubMed ID: 20929677
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
[TBL] [Abstract][Full Text] [Related]
35. MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells.
Tabruyn SP; Hansen S; Ojeda-Fernández ML; Bovy N; Zarrabeitia R; Recio-Poveda L; Bernabéu C; Martial JA; Botella LM; Struman I
Angiogenesis; 2013 Oct; 16(4):877-87. PubMed ID: 23800974
[TBL] [Abstract][Full Text] [Related]
36. SMAD4 mutations found in unselected HHT patients.
Gallione CJ; Richards JA; Letteboer TG; Rushlow D; Prigoda NL; Leedom TP; Ganguly A; Castells A; Ploos van Amstel JK; Westermann CJ; Pyeritz RE; Marchuk DA
J Med Genet; 2006 Oct; 43(10):793-7. PubMed ID: 16613914
[TBL] [Abstract][Full Text] [Related]
37. Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations.
Kilari S; Wang Y; Singh A; Graham RP; Iyer V; Thompson SM; Torbenson MS; Mukhopadhyay D; Misra S
JCI Insight; 2022 May; 7(9):. PubMed ID: 35380991
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a mutation in the zona pellucida module of Endoglin that causes Hereditary Hemorrhagic Telangiectasia.
Ruiz-Llorente L; Chiapparino E; Plumitallo S; Danesino C; Bayrak-Toydemir P; Pagella F; Manfredi G; Bernabeu C; Jovine L; Olivieri C
Gene; 2019 May; 696():33-39. PubMed ID: 30763665
[TBL] [Abstract][Full Text] [Related]
39. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
[TBL] [Abstract][Full Text] [Related]
40. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.
Ardelean DS; Letarte M
Front Genet; 2015; 6():35. PubMed ID: 25717337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
